TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Griewank, Klaus G ^a   Murali, Rajmohan ^b   Schilling, Bastian ^a   Schimming, Tobias ^a   Möller, Inga ^a   Moll, Iris ^a   Schwamborn, Marion ^a   Sucker, Antje ^a   Zimmer, Lisa ^a   Schadendorf, Dirk ^a   Hillen, Uwe ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MELANOMA; MUTATION; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS; TELOMERASE;

EID: 84894203228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080354     Document Type: Article

References (33)

1. Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30: 774-778. (Pubitemid 24157120)
2. Leiter U, Garbe C (2008) Epidemiology of melanoma and nonmelanoma skin cancer - the role of sunlight. Adv Exp Med Biol 624: 89-103.
3. Epstein EH (2008) Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 8: 743-754.
4. Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344: 975-983. (Pubitemid 32240317)
5. Rubin AI, Chen EH, Ratner D (2005) Basal-cell carcinoma. N Engl J Med 353: 2262-2269. (Pubitemid 41697289)
6. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, et al. (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-851. (Pubitemid 26192135)
7. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671. (Pubitemid 26200029)
8. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, et al. (1996) The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14: 78-81. (Pubitemid 26301550)
9. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, et al. (1998) Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 110: 885-888. (Pubitemid 28237693)
10. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, et al. (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391: 90-92. (Pubitemid 28079221)
11. Ling G, Ahmadian A, Persson A, Unden AB, Afink G, et al. (2001) PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 20: 7770-7778. (Pubitemid 33121950)
12. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, et al. (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 90: 4216-4220. (Pubitemid 23134197)
13. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, et al. (2012) Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 366: 2171-2179.
14. Ulrich C, Schmook T, Sachse MM, Sterry W, Stockfleth E (2004) Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 30: 622-627. (Pubitemid 38525892)
15. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 4: 196-202.
16. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 88: 10124-10128. (Pubitemid 21915787)
17. Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 122: 464-472.
18. Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, et al. (2011) Loss-offunction mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A 108: 17761-17766.
19. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, et al. (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339: 957-959.
20. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, et al. (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339: 959-961.
21. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, et al. (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A.
22. Landa I, Ganly I, Chan TA, Mitsutake N, Matsuse M, et al. (2013) Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease. J Clin Endocrinol Metab.
23. Vinagre J, Almeida A, Populo H, Batista R, Lyra J, et al. (2013) Frequency of TERT promoter mutations in human cancers. Nat Commun 4: 2185.
24. Griewank KG, Murali R, Schilling B, Scholz S, Sucker A, et al. (2013) TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer 109: 497-501.
25. Griewank K, Schilling B, Murali R, Bielefeld N, Schwamborn M, et al. (2013) TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas. Mod Pathol.
26. Scott GA, Laughlin TS, Rothberg PG (2013) Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma. Mod Pathol.
27. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
28. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, et al. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491: 56-65.
29. Blackburn EH (2005) Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 579: 859-862.
30. Gunes C, Rudolph KL (2013) The role of telomeres in stem cells and cancer. Cell 152: 390-393.
31. Kossard S EJ, EH, Cerio R, Yu LL, Weedon D (2006) Basal Cell Carcinoma. In: LeBoit PE BG, Weedon D, Sarasin A, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Skin Tumours Lyon: IARC Press. pp. 13-19
32. de Vries E BF, Coebergh JW, Cerroni L, Ruiter DJ, Elder DE, et al. (2006) Malignant melanoma: Introduction. In: LeBoit PE BG, Weedon D, Sarasin A, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Skin Tumours Lyon: IARC Press. pp. 52-65
33. Weedon D MM, Gross C, Nagore E, Yu LL (2006) Squamous Cell Carcinoma. In: LeBoit PE BG, Weedon D, Sarasin A, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Skin Tumours Lyon: IARC Press. pp. 20-25